Literature DB >> 24458982

VEGF increases paracellular permeability in brain endothelial cells via upregulation of EphA2.

Ziwei Miao1, Yanbin Dong, Wengang Fang, Deshu Shang, Dongxin Liu, Ke Zhang, Bo Li, Yu-Hua Chen.   

Abstract

Neurological disorders are associated with an increase in the permeability of human brain microvascular endothelial cells (HBMEC). Our previous findings have indicated that EphA2 could increase the permeability of HBMEC. Recent evidence has linked EphA2 and vascular endothelial growth factor (VEGF) to abnormalities in the vascular response. However, it is unclear whether EphA2 is involved in the VEGF-induced changes in the permeability of HBMEC. Here, changes in permeability were determined by measuring transendothelial electrical resistance (TEER) and the flux of FITC-dextran. We found that knockdown of EphA2 in HBMEC abolished the VEGF-induced reduction in TEER and increase in flux of fluorescent dextran. Moreover, VEGF-induced redistribution of ZO-1 and the recruitment of detergent-soluble occludin and claudin-5 were also prevented. Further results showed that VEGF increased EphA2 expression in a time- and dose-dependent manner, which was inhibited by a neutralizing antibody against VEGFR2 or SU1498. VEGF-induced EphA2 expression was suppressed in the brain endothelium following treatments with the PI3K inhibitor LY294002, Akt inhibitor or transfection with the dominant-negative PI3K mutants (Δp110). Similar results were obtained when ERK1/2 activation was inhibited by PD98059 or ERK1/2 siRNA transfection. Our data suggest that VEGF upregulates the expression of EphA2 in HBMEC through binding to VEGFR2 and subsequently activating the intracellular PI3K/Akt and ERK1/2 signaling pathways, which contribute to an increase in paracellular permeability. These data reveal a novel role for VEGF as a regulator of EphA2 expression in the brain endothelial cells and provide insights into the molecular mechanisms of VEGF-mediated changes in paracellular permeability.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ERK1/2; EphA2; PI3K/Akt; VEGF; human brain microvascular endothelial cell

Mesh:

Substances:

Year:  2014        PMID: 24458982     DOI: 10.1002/ar.22878

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  13 in total

Review 1.  Regulation of pulmonary endothelial barrier function by kinases.

Authors:  Nektarios Barabutis; Alexander Verin; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-23       Impact factor: 5.464

2.  EphA2 proteomics in human keratinocytes reveals a novel association with afadin and epidermal tight junctions.

Authors:  Bethany E Perez White; Rosa Ventrella; Nihal Kaplan; Calvin J Cable; Paul M Thomas; Spiro Getsios
Journal:  J Cell Sci       Date:  2016-11-04       Impact factor: 5.285

3.  Overexpression and correlation of HIF-2α, VEGFA and EphA2 in residual hepatocellular carcinoma following high-intensity focused ultrasound treatment: Implications for tumor recurrence and progression.

Authors:  Lun Wu; You-Shun Zhang; Meng-Liang Ye; Feng Shen; Wei Liu; Hong-Sheng Hu; Sheng-Wei Li; Hong-Wei Wu; Qin-Hua Chen; Wen-Bo Zhou
Journal:  Exp Ther Med       Date:  2017-05-04       Impact factor: 2.447

4.  Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Protects Blood-Brain Barrier Integrity Following Diffuse Axonal Injury by Decreasing the Levels of Inflammatory Mediators Through a Caveolin-1-Dependent Pathway.

Authors:  Yonglin Zhao; Xing Wei; Jinning Song; Ming Zhang; Tingqin Huang; Jie Qin
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

5.  The blood-brain barrier internalises Cryptococcus neoformans via the EphA2-tyrosine kinase receptor.

Authors:  Phylicia A Aaron; Mantana Jamklang; John P Uhrig; Angie Gelli
Journal:  Cell Microbiol       Date:  2018-01-18       Impact factor: 3.715

Review 6.  Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.

Authors:  Geetika Nehra; Bjoern Bauer; Anika M S Hartz
Journal:  Pharmacol Ther       Date:  2022-01-30       Impact factor: 13.400

7.  Effects of the duration of hyperlipidemia on cerebral lipids, vessels and neurons in rats.

Authors:  Weichun Yang; He Shi; Jianfen Zhang; Ziyi Shen; Guangyu Zhou; Minyu Hu
Journal:  Lipids Health Dis       Date:  2017-01-31       Impact factor: 3.876

8.  Induction of VEGFA and Snail-1 by meningitic Escherichia coli mediates disruption of the blood-brain barrier.

Authors:  Ruicheng Yang; Wentong Liu; Ling Miao; Xiaopei Yang; Jiyang Fu; Beibei Dou; Aoling Cai; Xin Zong; Chen Tan; Huanchun Chen; Xiangru Wang
Journal:  Oncotarget       Date:  2016-09-27

9.  Meningitic Escherichia coli-induced upregulation of PDGF-B and ICAM-1 aggravates blood-brain barrier disruption and neuroinflammatory response.

Authors:  Rui-Cheng Yang; Xin-Yi Qu; Si-Yu Xiao; Liang Li; Bo-Jie Xu; Ji-Yang Fu; Yu-Jin Lv; Nouman Amjad; Chen Tan; Kwang Sik Kim; Huan-Chun Chen; Xiang-Ru Wang
Journal:  J Neuroinflammation       Date:  2019-05-15       Impact factor: 8.322

10.  Differential transcription profiles of long non-coding RNAs in primary human brain microvascular endothelial cells in response to meningitic Escherichia coli.

Authors:  Ruicheng Yang; Fei Huang; Jiyang Fu; Beibei Dou; Bojie Xu; Ling Miao; Wentong Liu; Xiaopei Yang; Chen Tan; Huanchun Chen; Xiangru Wang
Journal:  Sci Rep       Date:  2016-12-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.